Clinical Trials Directory

Trials / Completed

CompletedNCT03805009

Efficacy of End-Effector Robot-Assisted Gait Training in Subacute Stroke Patients

Efficacy of End-Effector Robot-Assisted Gait Training in Subacute Stroke Patients: Clinical and Gait Outcomes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
26 (actual)
Sponsor
IRCCS San Raffaele Roma · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

To date, no studies seems to compare conventional gait rehabilitation program with end-effector RAGT in subacute stroke patients by analysing the variations of gait kinematics beyond clinical multi prospective outcomes. The aim of this pilot study is to evaluate the efficacy of end-effector RAGT in subacute stroke patients in terms of clinical outcomes and gait kinematics, comparing them with conventional gait rehabilitation program.

Detailed description

To evaluate the efficacy of end-effector RAGT in subacute stroke patients in terms of clinical outcomes and gait kinematics, comparing them with conventional gait rehabilitation program, patients following first ever stroke in sub-acute phase will be recruited and assessed both clinically and instrumentally (Gait Analysis) at baseline (T0) and at the end of training program (T1). The patients will be divided into 2 groups and will conduct two different types of gait training: one group will be recruited by IRCCS San Raffaele Pisana of Rome and will perform, in addition to conventional therapy, gait training using an end-effector robotic device for RAGT(Robotic Group, RG); and another group will be recruited by the Don Carlo Gnocchi Foundation Onlus of Rome, and will perform conventional gait rehabilitation program(Conventional Group, CG).

Conditions

Interventions

TypeNameDescription
DEVICERobot-Assisted Gait Training (RAGT)The Robotic Group (RG) performs a Robot-Assisted Gait Training (RAGT) using an end-effector robotic device (G-EO system-Reha Technology-Olten, Switzerland).

Timeline

Start date
2013-03-19
Primary completion
2017-12-31
Completion
2018-09-30
First posted
2019-01-15
Last updated
2024-04-10

Locations

2 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT03805009. Inclusion in this directory is not an endorsement.